Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings - Reuters
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQYkk0cFdtOFRtV0JRVF9lZE5IelR1dTRjZDVuNm9mRGJTTklPUEhGSThfc3djZkpqZVUxeGV6ZGM2c0xTd0Mxb0sxZWZVcGlCS0NqREJwX09kTFNzWjliVlBNR245XzNrUnhmZktqdmgzOXE2M2dVQVVYM3d5S1NCUVI4aUpxbEQ5eDd5TlBhMnQ3ZUQzN0ZVdmJ2ckkzR1gzODRpTU51QkJ5dlpyN201NVpwN1VBQm4wRXpObnFiZFVYZVdwZmY0?oc=5" target="_blank">Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Humana agrees not to reference Teva's Israel ties at US drug trial - Reuters
Humana agrees not to reference Teva's Israel ties at US drug trial Reuters
August 13, 2026 at 03:33 PMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMUS FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PMEyePoint's drug for age-related eye disease fails late-stage trial, shares tank - Reuters
EyePoint's drug for age-related eye disease fails late-stage trial, shares tank Reuters
August 17, 2026 at 03:45 PMUS FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PM